Ahrari S - Search Results

1

Structure and dynamics of inactive and active MARK4: conformational switching through the activation process.

Ahrari S, Mogharrab N, Navapour L. Ahrari S, et al. J Biomol Struct Dyn. 2020 May;38(8):2468-2481. doi: 10.1080/07391102.2019.1655479. Epub 2019 Sep 3. J Biomol Struct Dyn. 2020. PMID: 31411112

2

Interconversion of inactive to active conformation of MARK2: Insights from molecular modeling and molecular dynamics simulation.

Ahrari S, Mogharrab N, Navapour L. Ahrari S, et al. Arch Biochem Biophys. 2017 Sep 15;630:66-80. doi: 10.1016/j.abb.2017.07.002. Epub 2017 Jul 12. Arch Biochem Biophys. 2017. PMID: 28711359

3

Effects of T208E activating mutation on MARK2 protein structure and dynamics: Modeling and simulation.

Ahrari S, Mogharrab N. Ahrari S, et al. Mol Biol Res Commun. 2014 Sep;3(3):149-164. Mol Biol Res Commun. 2014. PMID: 27843979 Free PMC article.

4

Rational design and engineering of a mutant variant of urate oxidase as a therapeutic enzyme: a molecular dynamics simulation approach.

Ahrari S, Dabbagh F, Ahrari S, Ghasemi Y, Mogharrab N, Riazalhosseini Y. Ahrari S, et al. Curr Comput Aided Drug Des. 2016 Sep 5. Online ahead of print. Curr Comput Aided Drug Des. 2016. PMID: 27600879

5

MARK4 protein can explore the active-like conformations in its non-phosphorylated state.

Ahrari S, Khosravi F, Osouli A, Sakhteman A, Nematollahi A, Ghasemi Y, Savardashtaki A. Ahrari S, et al. Sci Rep. 2019 Sep 10;9(1):12967. doi: 10.1038/s41598-019-49337-0. Sci Rep. 2019. PMID: 31506531 Free PMC article.

6

Maltase-glucoamylase inhibition potency and cytotoxicity of pyrimidine-fused compounds: An in silico and in vitro approach.

Mehraban MH, Mansourian M, Ahrari S, HajiEbrahimi A, Odooli S, Motovali-Bashi M, Yousefi R, Ghasemi Y. Mehraban MH, et al. Among authors: ahrari s. Comput Biol Chem. 2019 Oct;82:25-36. doi: 10.1016/j.compbiolchem.2019.06.007. Epub 2019 Jun 19. Comput Biol Chem. 2019. PMID: 31255972

7

Application of molecular dynamics simulations to design a dual-purpose oligopeptide linker sequence for fusion proteins.

Rezaie E, Mohammadi M, Sakhteman A, Bemani P, Ahrari S. Rezaie E, et al. Among authors: ahrari s. J Mol Model. 2018 Oct 15;24(11):313. doi: 10.1007/s00894-018-3846-x. J Mol Model. 2018. PMID: 30324504

8

Disulfide bridge formation to increase thermostability of DFPase enzyme: A computational study.

Mohammadi M, Sakhteman A, Ahrari S, Hassanpour K, Hashemi SE, Farnoosh G. Mohammadi M, et al. Among authors: ahrari s. Comput Biol Chem. 2018 Dec;77:272-278. doi: 10.1016/j.compbiolchem.2018.09.005. Epub 2018 Sep 6. Comput Biol Chem. 2018. PMID: 30396154

9

Comparison of zn, cu, and fe content in hair and serum in alopecia areata patients with normal group.

Dastgheib L, Mostafavi-Pour Z, Abdorazagh AA, Khoshdel Z, Sadati MS, Ahrari I, Ahrari S, Ghavipisheh M. Dastgheib L, et al. Among authors: ahrari i, ahrari s. Dermatol Res Pract. 2014;2014:784863. doi: 10.1155/2014/784863. Epub 2014 Aug 27. Dermatol Res Pract. 2014. PMID: 25246935 Free PMC article.

10

CCR4 C1014T and CCL22 C16A genetic variations in the Iranian patients with colorectal adenocarcinoma.

Erfani N, Ahrari S, Ahrari I, Hosseini SV. Erfani N, et al. Among authors: ahrari i, ahrari s. Iran J Allergy Asthma Immunol. 2014 Dec;13(6):440-6. Iran J Allergy Asthma Immunol. 2014. PMID: 25148803 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters